Global Haemophilia Market - Analysis By Type (Haemophilia A, Haemophilia B), By Treatment (On-demand, Prophylaxis), By Region, By Country (2019 Edition): Opportunities and Forecasts (2013-2023) -– By Region (North America, Europe, APAC, ROW), By Country (U.S, Canada, Germany, UK, Japan, China, India, Brazil

Global Haemophilia Market - Analysis By Type (Haemophilia A, Haemophilia B), By Treatment (On-demand, Prophylaxis), By Region, By Country (2019 Edition): Opportunities and Forecasts (2013-2023) -– By Region (North America, Europe, APAC, ROW), By Country (U.S, Canada, Germany, UK, Japan, China, India, Brazil

Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Haemophilia Outlook

5. Global Haemophilia Market: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)

6. Global Haemophilia Market: Segment Analysis
6.1 Global Haemophilia Market Size, By Type: Breakdown (%)
6.1.1 Global Haemophilia Market Size, By Type, 2017 (%)
6.1.2 Global  Haemophilia Market Size, By Type, 2023 (%)
6.2 Global Haemophilia A Market, By Value (2013-2023)
6.3 Global Haemophilia B Market, By Value (2013-2023)
6.4 Global  Haemophilia Market Size, By Treatment: Breakdown (%)
6.4.1 Global Haemophilia Market Size, By Treatment, 2017 (%)
6.4.2 Global Haemophilia Market Size, By Treatment, 2023 (%)
6.5 Global On- demand Haemophilia Market, By Value (2013-2023)
6.6 Global Prophylaxis Market, By Value (2013-2023)

7. Global Haemophilia Market: Regional Analysis
7.1 Global Haemophilia Market Size, By Region : Breakdown (%)
7.1.1 Global Haemophilia Market Size, By Region, 2017 (%)
7.1.2 Global Haemophilia Market Size, By Region, 2023 (%)

7.2 North America Haemophilia Market: Growth and Forecast
7.2.1 By Value (2013-2017)
7.2.2 By Value (2018-2023)
7.2.3 By Type, By Value (2013-2017)
7.2.4 By Type, By Value (2018-2023)
7.2.5 By Treatment, By Value (2013-2017)
7.2.6 By Treatment, By Value (2018-2023)

7.3 North America Haemophilia Market: Country Analysis (U.S and Canada)
7.3.1 U.S Haemophilia Market, By Value (2013-2023)
7.3.2 U.S Haemophilia Market, By Type, By Value (2013-2017)
7.3.3 U.S Haemophilia Market, By Type, By Value (2018-2023)
7.3.4 U.S Haemophilia Market, By Treatment, By Value (2013-2017)
7.3.5 U.S Haemophilia Market, By Treatment, By Value (2018-2023)
7.3.6 Canada Haemophilia Market, By Value (2013-2023)
7.3.7 Canada Haemophilia Market, By Type, By Value (2013-2017)
7.3.8 Canada Haemophilia Market, By Type, By Value (2018-2023)
7.3.9 Canada Haemophilia Market, By Treatment, By Value (2013-2017)
7.3.10 Canada Haemophilia Market, By Treatment, By Value (2018-2023)

7.4 Europe Haemophilia Market: Growth and Forecast
7.4.1 By Value (2013-2017)
7.4.2 By Value (2018-2023)
7.4.3 By Type, By Value (2013-2017)
7.4.4 By Type, By Value (2018-2023)
7.4.5 By Treatment, By Value (2013-2017)
7.4.6 By Treatment, By Value (2018-2023)

7.5 Europe Haemophilia Market: Country Analysis (U.K and Germany)
7.5.1 U.K Haemophilia Market, By Value (2013-2023)
7.5.2 U.K Haemophilia Market, By Type, By Value (2013-2017)
7.5.3 U.K Haemophilia Market, By Type, By Value (2018-2023)
7.5.4 U.K Haemophilia Market, By Treatment, By Value (2013-2017)
7.5.5 U.K Haemophilia Market, By Treatment, By Value (2018-2023)
7.5.6 Germany Haemophilia Market, By Value (2013-2023)
7.5.7 Germany Haemophilia Market, By Type, By Value (2013-2017)
7.5.8 Germany Haemophilia Market, By Type, By Value (2018-2023)
7.5.9 Germany Haemophilia Market, By Treatment, By Value (2013-2017)
7.5.10 Germany Haemophilia Market, By Treatment, By Value (2018-2023)

7.6 APAC Haemophilia Market: Growth and Forecast
7.6.1 By Value (2013-2017)
7.6.2 By Value (2018-2023)
7.6.3 By Type, By Value (2013-2017)
7.6.4 By Type, By Value (2018-2023)
7.6.5 By Treatment, By Value (2013-2017)
7.6.6 By Treatment, By Value (2018-2023)

7.7 APAC Haemophilia Market: Country Analysis (Japan, India and China)
7.7.1 Japan Haemophilia Market, By Value (2013-2023)
7.7.2 Japan Haemophilia Market, By Type, By Value (2013-2017)
7.7.3 Japan Haemophilia Market, By Type, By Value (2018-2023)
7.7.4 Japan Haemophilia Market, By Treatment, By Value (2013-2017)
7.7.5 Japan Haemophilia Market, By Treatment, By Value (2018-2023)
7.7.6 India Haemophilia Market, By Value (2013-2023)
7.7.7 India Haemophilia Market, By Type, By Value (2013-2017)
7.7.8 India Haemophilia Market, By Type, By Value (2018-2023)
7.7.9 India Haemophilia Market, By Treatment, By Value (2013-2017)
7.7.10 India Haemophilia Market, By Treatment, By Value (2018-2023)
7.7.11 China Haemophilia Market, By Value (2013-2023)
7.7.12 China Haemophilia Market, By Type, By Value (2013-2017)
7.7.13 China Haemophilia Market, By Type, By Value (2018-2023)
7.7.14 China Haemophilia Market, By Treatment, By Value (2013-2017)
7.7.15 China Haemophilia Market, By Treatment, By Value (2018-2023)

7.8 ROW Haemophilia Market: Growth and Forecast
7.8.1 By Value (2013-2017)
7.8.2 By Value (2018-2023)
7.8.3 By Type, By Value (2013-2017)
7.8.4 By Type, By Value (2018-2023)
7.8.5 By Treatment, By Value (2013-2017)
7.8.6 By Treatment, By Value (2018-2023)

7.9 ROW Haemophilia Market: Country Analysis (Brazil)
7.9.1 Brazil Haemophilia Market, By Value (2013-2023)
7.9.2 Brazil Haemophilia Market, By Type, By Value (2013-2017)
7.9.3 Brazil Haemophilia Market, By Type, By Value (2018-2023)
7.9.4 Brazil Haemophilia Market, By Treatment, By Value (2013-2017)
7.9.5 Brazil Haemophilia Market, By Treatment, By Value (2018-2023)

8. Global Haemophilia Market Dynamics
8.1 Global Haemophilia Market Drivers
8.2 Global Haemophilia Market Restraints

9. Global Haemophilia Market Trends

10. Porter Five Force Analysis

11. SWOT Analysis

12. Supply Chain Analysis

13. Competitive Landscape

14. Policy and Regulatory Landscape

15. Company Profiles
15.1 Bayer
15.2 Novo Nordisk
15.3 Pfizer
15.4 Roche
15.5 Aptevo Therapeutics
15.6 Catalyst BioSciences
15.7 Dimension Therapeutics
15.8 Shire
15.9  CSL Behring
15.10 Alnylam Pharmaceuticals"    "List of Figures

Figure 1: Haemophilia Genetic Inheritance
Figure 2: Replacement Therapy for Haemophilia
Figure 3: Global Haemophilia Market Size, By Value, 2013-2017 (USD Billion)
Figure 4: Global Haemophilia Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 5: Age distribution of haemophilia patients in United states, In 2017
Figure 6: Number of People With Hemophilia, By Top 5 Countries, 2017
Figure 7: Number of People With Bleeding Disorders, Worldwide, By Specific Disease, In 2017
Figure 8: Number of People With Hemophilia, Worldwide, By Type, In 2017
Figure 9: Usage of Factor VIII (IU Per Capita)*, 2017
Figure 10: Usage of Factor IX Per Capita (IU Per Capita)#, 2017
Figure 11: United States Blood Plasma Collection, 2013-2016, in Million Liters
Figure 12: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Figure 13: Global Expected Healthcare Industry Outlook
Figure 14: Regional Expected Healthcare Industry Growth Rate By Year 2020
Figure 15: GDP Per Capita PPP, By Region, 2018 (in Thousand USD)
Figure 16: Projected global population aged 60 years & above (In Billions)
Figure 17: Global Haemophilia Market  Size, By Type, 2017 (In %)
Figure 18: Global Haemophilia Market  Size, By Type, 2023 (In %)
Figure 19: Global Haemophilia A Market, By Value, 2013-2017 (USD Billion)
Figure 20: Global Haemophilia A Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 21: Global Haemophilia B Market, By Value, 2013-2017 (USD Billion)
Figure 22: Global Haemophilia B Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 23: Global Haemophilia Market Size, By Treatment, 2017 (In %)
Figure 24: Global Haemophilia Market  Size, By Treatment, 2023 (In %)
Figure 25: Global On-demand Market, By Value, 2013-2017 (USD Billion)
Figure 26: Global On-demand Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 27: Global Prophylaxis Market, By Value, 2013-2017 (USD Billion)
Figure 28: Global Prophylaxis Market, By Value, Forecast, 2018-2023 (USD Billion)
Figure 29: Global Healthcare Landscape, By Select Region
Figure 30: Global Haemophilia  Market  Size, By Region, 2017 (%)
Figure 31: Global Haemophilia  Market  Size, By Region, 2023 (%)
Figure 32: North America Haemophilia Market Size, By Value, 2013-2017 (USD Billion)
Figure 33: North America Haemophilia Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 34: North America GDP, 2012-2017 (USD Trillion)
Figure 35: North America GDP per capita, current prices, 2013-2023F (In USD)
Figure 36: North America, Haemophilia diagnosis among children, 2017 (%)
Figure 37: Causes of acquired haemophilia
Figure 38: Percentage of patients obtaining blood, In 2017, In North America
Figure 39: Annualized healthcare cost per patient with haemophilia
Figure 40: North America Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 41: North America Haemophilia Market: By Type, By Value, 2018E-2023F (USD Billion)
Figure 42: North America Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
Figure 43: North America Haemophilia Market: By Treatment, By Value, 2018E-2023F (USD Billion)
Figure 44: U.S. Haemophilia Market Size, By Value, 2013-2023 (USD Billion)
Figure 45: U.S., Per Capita Expenditure on Healthcare, 2012-2018 (In USD)
Figure 46: Contribution to total national health expenditures in United States, In 2017
Figure 47: Percentage of people with Haemophilia A in United States, In 2017
Figure 48: U.S., GDP (Current USD), 2013-2017 (In USD Trillion)
Figure 49: U.S. Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 50: U.S. Haemophilia Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 51: U.S. Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
Figure 52: U.S. Haemophilia Market: By Treatment , By Value, 2018-2023 (USD Billion)
Figure 53: Canada Haemophilia Market Size, By Value, 2013-2023 (USD Billion)
Figure 54: Canada, Expenditure on Health as a share of GDP, 2012-2017 (in %)
Figure 55: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)
Figure 56: Prevalence of bleeding disorder in Canada
Figure 57: Usage of clotting factors in Canada, In 2017
Figure 58: Canada Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 59: Canada Haemophilia Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 60: Canada Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
Figure 61: Canada Haemophilia Market: By Treatment , By Value, 2018-2023 (USD Billion)
Figure 62: Europe Haemophilia Market Size, By Value, 2013-2017 (USD Billion)
Figure 63: Europe Haemophilia Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 64: Per Capita Health Expenditure, By Select Country, 2017 (USD)
Figure 65: GDP, Europe Region, By Select Country, 2017 (In Trillion USD)
Figure 66: Estimated distribution of per patient cost of haemophilia, Europe, In 2017 (EUR)
Figure 67: Breakdown of Total Health Expenditure in Europe, 2018 (%)
Figure 68: Major Players in Haemophilia Market in Europe
Figure 69: Europe Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 70: Europe Haemophilia Market: By Type, By Value, 2018E-2023F (USD Billion)
Figure 71: Europe Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
Figure 72: Europe Haemophilia Market: By Treatment, By Value, 2018E-2023F (USD Billion)
Figure 73: U.K Haemophilia Market Size, By Value, 2013-2023 (USD Billion)
Figure 74: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 75: Haemophilia patients in United Kingdom, yearly basis comparison, In number
Figure 76: Prevalence of bleeding disorder in United Kingdom, In 2017
Figure 77: Usage of clotting factors in United Kingdom, In 2017
Figure 78: U.K. Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 79: U.K. Haemophilia Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 80: U.K. Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
Figure 81: U.K. Haemophilia Market: By Treatment , By Value, 2018-2023 (USD Billion)
Figure 82: Germany Haemophilia Market Size, By Value, 2013-2023 (USD Billion)
Figure 83: Usage of clotting factors in Germany, In 2017
Figure 84: Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 85: Average annual percent growth in GDP, 2016 (USD)
Figure 86: Germany Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 87: Germany Haemophilia Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 88: Germany Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
Figure 89: Germany Haemophilia Market: By Treatment , By Value, 2018-2023 (USD Billion)
Figure 90: APAC Endoscopy Market Size, By Value, 2013-2017 (USD Billion)
Figure 91: APAC Endoscopy Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 92: Willingness in countries to donate blood, In 2016
Figure 93: World health expenditure as % of GDP
Figure 94: APAC, GDP, By Select Country, 2017 (In USD Trillion)
Figure 95: Diagnosis and treatment rates of haemophilia in APAC, In Asia, In 2017
Figure 96: Disparities in diagnosis of Haemophilia worldwide
Figure 97: APAC Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 98: APAC Haemophilia Market: By Type, By Value, 2018E-2023F (USD Billion)
Figure 99: APAC Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
Figure 100: APAC Haemophilia Market: By Treatment, By Value, 2018E-2023F (USD Billion)
Figure 101: Japan Haemophilia  Market Size, By Value, 2013-2023 (USD Billion)
Figure 102: Japan, GDP Growth Per Year, 2015-2019F (In %)
Figure 103: Japan Healthcare Expenditure Outlook (%)
Figure 104: Prevalence of bleeding disorder in Japan, In 2017
Figure 105: Usage of clotting factor in Japan, In 2017
Figure 106: Japan Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 107: Japan Haemophilia Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 108: Japan Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
Figure 109: Japan Haemophilia Market: By Treatment , By Value, 2018-2023 (USD Billion)
Figure 110: India Endoscopy Market Size, By Value, 2013-2023 (USD Billion)
Figure 111: Countries with highest rates of haemophilia, In 2017
Figure 112: Key factors affecting the Indian Haemophilia Treatment Industry
Figure 113: India, Total Population, 2013-2023F (In Billion)
Figure 114: India, Share of Urban Population, 2012-2017 (In %)
Figure 115: India, GDP Growth Per Year, 2015-2019 (In %)
Figure 116: Prevalence of bleeding disorder in India, In 2017
Figure 117: India Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 118: India Haemophilia Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 119: India Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
Figure 120: India Haemophilia Market: By Treatment , By Value, 2018-2023 (USD Billion)
Figure 121: India Haemophilia Market: By Treatment , By Value, 2018-2023 (USD Billion)
Figure 122: China Healthcare Expenditure Outlook (%)
Figure 123: China, GDP Growth Per Year, 2015-2019 (In %)
Figure 124: China, Share of Urban Population, 2012-2017 (In %)
Figure 125: China, Total Population, 2013-2021F (In Billion)
Figure 126: Prevalence of bleeding disorder in China, In 2017
Figure 127: Age  distribution for haemophilia patients in China, In 2017, In %
Figure 128: China Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 129: China Haemophilia Market: By Type, By Value, 2018E-2023F (USD Billion)
Figure 130: China Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
Figure 131: China Haemophilia Market: By Treatment, By Value, 2018E-2023F (USD Billion)
Figure 132: ROW Haemophilia Market Size, By Value, 2013-2023 (USD Billion)
Figure 133: Middle East and North Africa, GDP, 2012-2017 (In USD Trillion)
Figure 134: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %)
Figure 135: Top 10 fastest growing economies, 2018, (In%)
Figure 136: Percentage of people with haemophilia A in Latin America, In 2017
Figure 137: ROW Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 138: ROW Haemophilia Market: By Type, By Value, 2018E-2023F (USD Billion)
Figure 139: ROW Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
Figure 140: ROW Haemophilia Market: By Treatment, By Value, 2018E-2023F (USD Billion)
Figure 141: Brazil Haemophilia Market Size, By Value, 2013-2023 (USD Million)
Figure 142: Brazil, GDP, 2012-2017 (In USD Trillion)
Figure 143: Brazil health expenditure as a share of GDP, 2016
Figure 144: Prevalence of bleeding disorder in Brazil
Figure 145: Inhibitor formation in hemophiliac patients, In Brazil, In 2017
Figure 146: Brazil Haemophilia Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 147: Brazil Haemophilia Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 148: Brazil Haemophilia Market: By Treatment , By Value, 2013-2017 (USD Billion)
Figure 149: Brazil Haemophilia Market: By Treatment , By Value, 2018-2023 (USD Billion)
Figure 150: Working of traditional factors vs. half life factors
Figure 151: Bayer, Sales Revenue, 2013-2017 (USD Billion)
Figure 152: Bayer, Sales, By Business Segment, FY ended March 2017 (%)
Figure 153: Bayer , Sales, By Geographic  region, FY ended March 2017 (%)
Figure 154: Novo Nordisk, Net Sales, 2014-2018 (In Million USD)
Figure 155: Novo Nordisk, Net Sales, By Business Sector, 2018 (In %)
Figure 156: Novo Nordisk, Net Sales, By Geographic Region, 2018 (In %)
Figure 157: Pfizer, Sales Revenue, 2013-2017 (USD million)
Figure 158: Pfizer, Sales, By Business Segment, FY ended March 2017 (In %)
Figure 159: Pfizer, Sales, By Business Segment, FY ended March 2017 (In %)
Figure 160: Pfizer, Sales, By Business Segment, FY ended March 2017 (In %)
Figure 161: Roche, Sales, By Business Segment, FY ended March 2018 (%)
Figure 162: Roche, By Region, FY ended March 2018 (%)
Figure 163: Aptevo Therapeutics, Sales Revenue, 2015-2018 (USD Million)
Figure 164: Shire, Sales Revenue, 2016-2017 (USD Million)
Figure 165: Shire, Sales, By Business Segment, FY ended March 2017 (%)
Figure 166: Shire, By Region, FY ended March 2017 (%)

List of Tables

Table A: Classification of haemophilia depending upon severity level
Table B: Treatment options for Haemophilia
Table C: Facts about Haemophilia
Table D: Types of Prophylaxis
Table E: Prophylaxis over On-demand
Table F: Advantages of Prophylaxis
Table G: Facts about blood donation in North America
Table H: Estimated Haemophilia Insights, In Europe, In 2017
Table I: Germany, Healthcare Related Statistics, 2017
Table J: Global Access to Healthcare Index, Ranking of Select Countries in Asia Pacific Region, 2017 (score out of 10)
Table K: Coverage of population with health insurance  in Latin America, 2017, (In%)
Table L: Prevalence of different types of bleeding in haemophilia, In Africa, In 2018
Table M: Frequency of hemarthrosis in different joints in South Africa, In 2018, In %
Table N: Healthcare spending pattern in Brazil (In USD)
Table O: Recent novel gene therapy products for treating Haemophilia
Table P: Global Endoscopes Market, By Company Share, 2018 (%)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs